Yoo G H, Xu H J, Brennan J A, Westra W, Hruban R H, Koch W, Benedict W F, Sidransky D
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland 21205-2196.
Cancer Res. 1994 Sep 1;54(17):4603-6.
Our recent allelic analysis of head and neck squamous cell carcinomas identified a high incidence of chromosomal loss on 13q. To further define an area of minimal loss, we tested 60 primary head and neck squamous cell carcinomas in 59 patients for loss of heterozygosity (LOH) by using 10 polymorphic microsatellite markers spanning the long arm of chromosome 13. We examined the same primary tumors for inactivation of the retinoblastoma (Rb) gene by immunohistochemical analysis of paraffin-embedded specimens. Thirty-one of 60 (52%) tumors demonstrated LOH in at least one 13q marker. Twenty-nine of 31 (94%) lost a portion of 13q that included D13s133, which lies just telomeric to the Rb gene at 13q14.3. However, immunohistochemical staining revealed absence of Rb protein in only 6 of these 31 tumors (19.4%) with LOH. All but one tumor without LOH on 13q displayed normal Rb protein staining. Although Rb may be inactivated by an unusual mechanism in some head and neck squamous cell carcinomas, our data suggest that another tumor suppressor gene locus at 13q14 is likely to be involved in head and neck tumor progression.
我们最近对头颈部鳞状细胞癌进行的等位基因分析发现,13号染色体长臂存在高频率的染色体缺失。为了进一步确定最小缺失区域,我们使用跨越13号染色体长臂的10个多态性微卫星标记,对59例患者的60例原发性头颈部鳞状细胞癌进行杂合性缺失(LOH)检测。我们通过对石蜡包埋标本进行免疫组织化学分析,检测同一原发性肿瘤中视网膜母细胞瘤(Rb)基因的失活情况。60例肿瘤中有31例(52%)在至少一个13q标记上显示出LOH。31例中有29例(94%)丢失了13q的一部分,其中包括位于13q14.3的Rb基因端粒侧的D13s133。然而,免疫组织化学染色显示,在这31例具有LOH的肿瘤中,只有6例(19.4%)没有Rb蛋白。除1例13q无LOH的肿瘤外,所有肿瘤的Rb蛋白染色均正常。虽然在某些头颈部鳞状细胞癌中,Rb可能通过一种不寻常的机制失活,但我们的数据表明,13q14处的另一个肿瘤抑制基因位点可能参与头颈部肿瘤的进展。